Legend Biotech Corp.
Key Metrics
Market Snapshot
About
Legend Biotech Corporation is a clinical-stage biopharmaceutical company developing novel cell therapies for oncology and other indications. The company's lead product candidate, CARVYKTI (ciltacabtagene autoleucel), is a CAR-T therapy approved for treating multiple myeloma. Legend Biotech collaborates with Janssen Biotech to commercialize and develop its CAR-T platform globally.